About this trial

The aim of this clinical study is to evaluate the efficacy of reinforced inpatient aftercare versus usual care on the percentage of days of abstinence during the first year following withdrawal in adults with alcohol use disorders undergoing inpatient withdrawal. The hypothesis is that reinforced post-withdrawal follow-up, of the motivational interview type, during the first 4 months following hospitalisation, in addition to the usual care, would allow :

* Increase the percentage of days of abstinence in the year following withdrawal. * Reduce the rate of relapse in the year following withdrawal. * An increase in the cumulative and maximum duration of abstinence, an increase in motivation to maintain the change initiated and a reduction in the use of other substances in the year following withdrawal. * A reduction in the impact of risk factors involved in the relapse process in the year following withdrawal.

All participants will have assessments to monitor their abstinence and consumption. In addition to their assessments, the experimental group will have motivational talks once every 15 days.

Eligibility criteria

Qualifiers

With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months).

Being treated for withdrawal in hospital.

With a goal of complete abstinence.

With a means of communication (telephone).

Disqualifiers

Lack of understanding (written and spoken) of the French language.

Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction.

Eviction from the department, discharge against medical advice during hospitalisation for withdrawal.

Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up.

Trial design

Treatments tested in this trial

  • Experimental group : PSH (usual care) with motivational interviewing

Treatment groups

104 Participants
are divided into 2 treatment groups

Locations

1
Thomas RISDORFER DE ISSDENTZI3400, Montpellier France

Sponsors and collaborators

University Hospital, Montpellier

Lead sponsor